[Progress in the study of new cancer target Cdk5 and its inhibitors].

Long-xing Miao, Gaoyun Hu, Qianbin Li(Central South University), Zeyu Wang(Anhui University), Yijun Yang

PubMed

February 1, 2016

Cited by 0

Related Papers

Glioma targeted therapy: insight into future of molecular approaches

|Molecular Cancer|2022|727

Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer

|Journal of Experimental & Clinical Cancer Research|2021|535

Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts

|Journal of Hematology & Oncology|2022|273

Single-cell RNA-sequencing atlas reveals an MDK-dependent immunosuppressive environment in ErbB pathway-mutated gallbladder cancer

|Journal of Hepatology|2021|215

The adaptive transition of glioblastoma stem cells and its implications on treatments

|Signal Transduction and Targeted Therapy|2021|155